Request for Notification From Industry Organizations Interested in Participating in the Selection Process for Nonvoting Industry Representatives and Request for Nominations for Nonvoting Industry Representatives on the Tobacco Products Scientific Advisory Committee, 61006-61007 [2012-24560]
Download as PDF
61006
Federal Register / Vol. 77, No. 194 / Friday, October 5, 2012 / Notices
IV. Nomination Procedures
Any interested person may nominate
one or more qualified persons for
membership on one or more of the
advisory panels or advisory committees.
Self-nominations are also accepted.
Nominations must include a current,
complete resume or curriculum vitae for
each nominee, and their current
business address and/or home address,
telephone number, and email address if
available. Nominations must specify the
advisory committee(s) for which the
nominee is recommended. Nominations
must also acknowledge that the
nominee is aware of the nomination
unless self-nominated. FDA will ask
potential candidates to provide detailed
information concerning such matters
related to financial holdings,
employment, and research grants and/or
contracts to permit evaluation of
possible sources of conflict of interest.
This notice is issued under the
Federal Advisory Committee Act (5
U.S.C. app. 2) and 21 CFR part 14
relating to advisory committees.
Dated: September 25, 2012.
Jill Hartzler Warner,
Acting Associate Commissioner for Special
Medical Programs.
[FR Doc. 2012–24554 Filed 10–4–12; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2012–N–0001]
Request for Notification From Industry
Organizations Interested in
Participating in the Selection Process
for Nonvoting Industry
Representatives and Request for
Nominations for Nonvoting Industry
Representatives on the Tobacco
Products Scientific Advisory
Committee
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is requesting that
industry organizations interested in
participating in the selection of a
nonvoting industry representative to
represent the interests of tobacco
growers, to serve on its Tobacco
Products Scientific Advisory
Committee, notify FDA in writing. A
nominee may either be self-nominated
or nominated by an organization to
serve as a nonvoting industry
representative. Nominations will be
pmangrum on DSK3VPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
15:25 Oct 04, 2012
Jkt 229001
accepted for the upcoming vacancy
effective with this notice.
DATES: Any industry organization
interested in participating in the
selection of an appropriate nonvoting
member to represent the interests of
tobacco growers must send a letter
stating the interest to FDA by November
5, 2012, for the vacancy listed in the
notice. Concurrently, nomination
materials for prospective candidates
should be sent to FDA by November 5,
2012.
ADDRESSES: All letters of interest and
nominations should be submitted in
writing to TPSAC@fda.hhs.gov, or by
mail to Caryn Cohen (see FOR FURTHER
INFORMATION CONTACT).
FOR FURTHER INFORMATION CONTACT:
Caryn Cohen, Center for Tobacco
Products, Food and Drug
Administration, 9200 Corporate Blvd.,
Rockville, MD 20850, 1–877–287–1373
(choose Option 4), Fax: 240–276–3655,
TPSAC@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: The
Agency requests nominations for a
nonvoting industry representative on
the Tobacco Products Scientific
Advisory Committee to represent the
interests of tobacco growers. Elsewhere
in this issue of the Federal Register,
FDA is publishing a separate document
announcing the Request for Notification
for Voting Members on the Tobacco
Products Scientific Advisory
Committee.
I. Tobacco Products Scientific Advisory
Committee
The Tobacco Products Scientific
Advisory Committee (the Committee)
advises the Commissioner of Food and
Drugs (the Commissioner) or designee in
discharging responsibilities as they
relate to the regulation of tobacco
products. The Committee reviews and
evaluates safety, dependence, and
health issues relating to tobacco
products and provides appropriate
advice, information and
recommendations to the Commissioner.
The Committee includes three
nonvoting members who represent
industry interests. These members
include one representative of the
tobacco manufacturing industry, one
representative of the interests of tobacco
growers, and one representative of the
interests of the small business tobacco
manufacturing industry. The
representative of the interests of the
small business tobacco manufacturing
industry may be filled on a rotating
basis by representatives of different
small business tobacco manufacturers
based on areas of expertise relevant to
the topics being considered by the
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
Committee. With this notice,
nominations are sought for one
representative of the interests of tobacco
growers, and an alternate to this
representative.
II. Selection Procedure
Any industry organization interested
in participating in the selection of
appropriate nonvoting member(s) to
represent industry interests should send
a letter stating that interest to the FDA
contact (see FOR FURTHER INFORMATION
CONTACT) within 30 days of publication
of this document (see DATES). Within 50
days of publication of this document,
FDA will send a letter to each
organization that has expressed an
interest, attaching a complete list of all
such organizations, and a list of all
nominees along with their current
resumes. The letter will also state that
it is the responsibility of the interested
organizations to confer with one another
and to select a candidate, within 60
days of the receipt of the letter, to serve
as the nonvoting member to represent
the interests of the tobacco growers on
the Committee. The interested
organizations are not bound by the list
of nominees in selecting a candidate.
However, if no individual is selected
within 60 days, the Commissioner will
select the nonvoting member to
represent industry interests.
III. Application Procedure
Individuals may self-nominate and/or
organizations may nominate one or
more individuals to serve as a nonvoting
industry representative (for the roles
specified previously in this notice).
Nominations must include a current
resume or curriculum vitae of the
nominee including current business
address and/or home address, telephone
number, email address if available, and
the role for which the individual is
being nominated. Nominations must
also acknowledge that the nominee is
aware of the nomination unless selfnominated. FDA will forward all
nominations to the organizations
expressing interest in participating in
the selection process for the committee.
(Persons who nominate themselves as
nonvoting industry representatives will
not participate in the selection process.)
FDA seeks to include the views of
women and men, members of all racial
and ethnic groups, and individuals with
and without disabilities on its advisory
committees and, therefore, encourages
nominations of appropriately qualified
candidates from these groups.
This notice is issued under the
Federal Advisory Committee Act (5
U.S.C. app. 2) and 21 CFR part 14,
relating to advisory committees.
E:\FR\FM\05OCN1.SGM
05OCN1
Federal Register / Vol. 77, No. 194 / Friday, October 5, 2012 / Notices
Dated: September 25, 2012.
Jill Hartzler Warner,
Acting Associate Commissioner for Special
Medical Programs.
[FR Doc. 2012–24560 Filed 10–4–12; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2012–N–0001]
Request for Nominations for Voting
Members on a Public Advisory
Committee; Tobacco Products
Scientific Advisory Committee
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is requesting
nominations for voting members to
serve on the Tobacco Products Scientific
Advisory Committee, Office of Science,
Center for Tobacco Products.
FDA seeks to include the views of
women and men, members of all racial
and ethnic groups, and individuals with
and without disabilities on its advisory
committees and, therefore encourages
nominations of appropriately qualified
candidates from these groups.
DATES: Nominations received on or
before December 4, 2012, will be given
first consideration for membership on
the Tobacco Products Scientific
Advisory Committee. Nominations
received after December 4, 2012, will be
considered for nomination to the
committee as later vacancies occur.
ADDRESSES: All nominations for
membership should be sent
electronically to cv@oc.fda.gov or by
mail to Advisory Committee Oversight
and Management Staff, Food and Drug
Administration, 10903 New Hampshire
Ave., Bldg. 32, Rm. 5103, Silver Spring,
MD 20993–0002.
FOR FURTHER INFORMATION CONTACT:
Regarding all nomination questions for
membership, the primary contact is:
Caryn Cohen, Center for Tobacco
Products, Food and Drug
Administration, 9200 Corporate Blvd.,
Rockville, MD 20850, 1–877–287–1373
(choose Option 4), FAX: 240–276–3655,
TPSAC@fda.hhs.gov.
Information about becoming a
member on an FDA advisory committee
can also be obtained by visiting FDA’s
Web site at https://www.fda.gov/
AdvisoryCommittees/default.htm.
SUPPLEMENTARY INFORMATION: FDA is
requesting nomination for voting
pmangrum on DSK3VPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
15:25 Oct 04, 2012
Jkt 229001
members on the Tobacco Products
Scientific Advisory Committee.
Elsewhere in this issue of the Federal
Register, FDA is publishing a separate
document announcing the Request for
Notification for Nonvoting Members on
the Tobacco Products Scientific
Advisory Committee.
I. General Description of the Committee
Duties
The Tobacco Products Scientific
Advisory Committee advises the
Commissioner of Food and Drugs (the
Commissioner) or designee in
discharging responsibilities as they
relate to the regulation of tobacco
products. The Committee reviews and
evaluates safety, dependence, and
health issues relating to tobacco
products and provides appropriate
advice, information and
recommendations to the Commissioner.
II. Criteria for Voting Members
The Committee shall consist of 12
members including the Chair. Members
and the Chair are selected by the
Commissioner or designee from among
individuals knowledgeable in the fields
of medicine, medical ethics, science, or
technology involving the manufacture,
evaluation, or use of tobacco products.
Members will be invited to serve for
overlapping terms of up to 4 years.
Almost all non-Federal members of this
committee serve as Special Government
Employees. The Committee shall
include nine technically qualified
voting members, selected by the
Commissioner or designee. The nine
voting members shall be physicians,
dentists, scientists, or health care
professionals practicing in the area of
oncology, pulmonology, cardiology,
toxicology, pharmacology, addiction, or
any other relevant specialty.
In addition to the voting members, the
committee shall include three nonvoting
members who are identified with
industry interests. These members shall
include one representative of the
tobacco manufacturing industry, one
representative of the interests of tobacco
growers, and one representative of the
interests of the small business tobacco
manufacturing industry.
III. Nomination Procedures
Any interested person may nominate
one or more qualified individuals for
membership on the advisory committee.
Self-nominations are also accepted.
Nominations must include a current,
complete resume or curriculum vitae for
each nominee, including current
business address and/or home address,
telephone number, and email address if
available. Nominations must also
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
61007
specify the advisory committee for
which the nominee is recommended.
Nominations must also acknowledge
that the nominee is aware of the
nomination unless self-nominated. FDA
will ask potential candidates to provide
detailed information concerning such
matters related to financial holdings,
employment, and research grants and/or
contracts to permit evaluation of
possible sources of conflicts of interest.
This notice is issued under the
Federal Advisory Committee Act (5
U.S.C. app. 2) and 21 CFR part 14,
relating to advisory committees.
Dated: September 24, 2012.
Jill Hartzler Warner,
Acting Associate Commissioner for Special
Medical Programs.
[FR Doc. 2012–24476 Filed 10–3–12; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities; Proposed Collection:
Comment Request
In compliance with the requirement
for opportunity for public comment on
proposed data collection projects
(section 3506(c)(2)(A) of Title 44, United
States Code, as amended by the
Paperwork Reduction Act of 1995, Pub.
L. 104–13), the Health Resources and
Services Administration (HRSA)
publishes periodic summaries of
proposed projects being developed for
submission to the Office of Management
and Budget (OMB) under the Paperwork
Reduction Act of 1995. To request more
information on the proposed project or
to obtain a copy of the data collection
plans and draft instruments, email
paperwork@hrsa.gov or call the HRSA
Reports Clearance Officer at (301) 443–
1984.
Comments are invited on: (a) The
proposed collection of information for
the proper performance of the functions
of the agency; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology.
Proposed Project: HRSA National
Environmental Policy Act (NEPA)
Environmental Information and
E:\FR\FM\05OCN1.SGM
05OCN1
Agencies
[Federal Register Volume 77, Number 194 (Friday, October 5, 2012)]
[Notices]
[Pages 61006-61007]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-24560]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2012-N-0001]
Request for Notification From Industry Organizations Interested
in Participating in the Selection Process for Nonvoting Industry
Representatives and Request for Nominations for Nonvoting Industry
Representatives on the Tobacco Products Scientific Advisory Committee
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is requesting that
industry organizations interested in participating in the selection of
a nonvoting industry representative to represent the interests of
tobacco growers, to serve on its Tobacco Products Scientific Advisory
Committee, notify FDA in writing. A nominee may either be self-
nominated or nominated by an organization to serve as a nonvoting
industry representative. Nominations will be accepted for the upcoming
vacancy effective with this notice.
DATES: Any industry organization interested in participating in the
selection of an appropriate nonvoting member to represent the interests
of tobacco growers must send a letter stating the interest to FDA by
November 5, 2012, for the vacancy listed in the notice. Concurrently,
nomination materials for prospective candidates should be sent to FDA
by November 5, 2012.
ADDRESSES: All letters of interest and nominations should be submitted
in writing to TPSAC@fda.hhs.gov, or by mail to Caryn Cohen (see FOR
FURTHER INFORMATION CONTACT).
FOR FURTHER INFORMATION CONTACT: Caryn Cohen, Center for Tobacco
Products, Food and Drug Administration, 9200 Corporate Blvd.,
Rockville, MD 20850, 1-877-287-1373 (choose Option 4), Fax: 240-276-
3655, TPSAC@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: The Agency requests nominations for a
nonvoting industry representative on the Tobacco Products Scientific
Advisory Committee to represent the interests of tobacco growers.
Elsewhere in this issue of the Federal Register, FDA is publishing a
separate document announcing the Request for Notification for Voting
Members on the Tobacco Products Scientific Advisory Committee.
I. Tobacco Products Scientific Advisory Committee
The Tobacco Products Scientific Advisory Committee (the Committee)
advises the Commissioner of Food and Drugs (the Commissioner) or
designee in discharging responsibilities as they relate to the
regulation of tobacco products. The Committee reviews and evaluates
safety, dependence, and health issues relating to tobacco products and
provides appropriate advice, information and recommendations to the
Commissioner. The Committee includes three nonvoting members who
represent industry interests. These members include one representative
of the tobacco manufacturing industry, one representative of the
interests of tobacco growers, and one representative of the interests
of the small business tobacco manufacturing industry. The
representative of the interests of the small business tobacco
manufacturing industry may be filled on a rotating basis by
representatives of different small business tobacco manufacturers based
on areas of expertise relevant to the topics being considered by the
Committee. With this notice, nominations are sought for one
representative of the interests of tobacco growers, and an alternate to
this representative.
II. Selection Procedure
Any industry organization interested in participating in the
selection of appropriate nonvoting member(s) to represent industry
interests should send a letter stating that interest to the FDA contact
(see FOR FURTHER INFORMATION CONTACT) within 30 days of publication of
this document (see DATES). Within 50 days of publication of this
document, FDA will send a letter to each organization that has
expressed an interest, attaching a complete list of all such
organizations, and a list of all nominees along with their current
resumes. The letter will also state that it is the responsibility of
the interested organizations to confer with one another and to select a
candidate, within 60 days of the receipt of the letter, to serve as the
nonvoting member to represent the interests of the tobacco growers on
the Committee. The interested organizations are not bound by the list
of nominees in selecting a candidate. However, if no individual is
selected within 60 days, the Commissioner will select the nonvoting
member to represent industry interests.
III. Application Procedure
Individuals may self-nominate and/or organizations may nominate one
or more individuals to serve as a nonvoting industry representative
(for the roles specified previously in this notice). Nominations must
include a current resume or curriculum vitae of the nominee including
current business address and/or home address, telephone number, email
address if available, and the role for which the individual is being
nominated. Nominations must also acknowledge that the nominee is aware
of the nomination unless self-nominated. FDA will forward all
nominations to the organizations expressing interest in participating
in the selection process for the committee. (Persons who nominate
themselves as nonvoting industry representatives will not participate
in the selection process.)
FDA seeks to include the views of women and men, members of all
racial and ethnic groups, and individuals with and without disabilities
on its advisory committees and, therefore, encourages nominations of
appropriately qualified candidates from these groups.
This notice is issued under the Federal Advisory Committee Act (5
U.S.C. app. 2) and 21 CFR part 14, relating to advisory committees.
[[Page 61007]]
Dated: September 25, 2012.
Jill Hartzler Warner,
Acting Associate Commissioner for Special Medical Programs.
[FR Doc. 2012-24560 Filed 10-4-12; 8:45 am]
BILLING CODE 4160-01-P